01:45 PM EDT, 03/12/2024 (MT Newswires) -- Thomas Richard Kassberg, Chief Business Officer & Executive Vice President, on March 11, 2024, sold 11,509 shares in Ultragenyx Pharmaceutical ( RARE ) for $574,644. Following the Form 4 filing with the SEC, Kassberg has control over a total of 252,823 shares of the company, with 252,823 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1515673/000095017024029780/xslF345X03/ownership.xml

Price: 47.53, Change: -0.98, Percent Change: -2.02